Please provide your email address to receive an email when new articles are posted on . Compared with cytochrome P-450 2C9 (CYP2C9), genetic variability in the pharmacologic target of warfarin, ...

This case–control study enrolled 26 consecutive white patients (mean age 74.2 years, 17 women) who presented with acute, NSAID-related gastroduodenal bleeding identified by endoscopy, and 52 control ...

HUDSON, NY--(Marketwire - Sep 17, 2012) - Taconic and CXR Biosciences Ltd are pleased to announce the publication of two manuscripts describing novel mouse lines humanized for the important drug ...

Genetic variations in cytochrome P450 2C9 (CYP2C9) contribute to interindividual variability in the metabolism of clinically used drugs such as warfarin and tolbutamide. We functionally characterized ...

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus, evidence-based recommendations to aid in the design and ...

ROCKVILLE, Md. - May 9, 2019 -The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus, evidence-based recommendations to ...

Scientists at the city-based Centre for Cellular and Molecular Biology (CCMB) have decoded the gene that helps in the metabolism of medicines in the body, paving way towards personalised medicine.

Population-specific trials and not common drug clinical trials for the entire world for any new medicine is important because of the presence of variant genes responsible for drug metabolism, say ...